In which of your patients with FH do you feel PSCK9 inhibitors will become foundational agents, in conjunction with statins, when tolerated?

In which of your patients with FH do you feel PSCK9 inhibitors will become foundational agents, in conjunction with statins, when tolerated?

In which of your patients with FH do you feel PSCK9 inhibitors will become foundational agents, in conjunction with statins, when tolerated?


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Medical Cardiology, Interventional Cardiology, Lipid Medicine, Atherosclerosis and Diabetes Specialist's Perspective

Presenter

Stephen Nicholls, MD

Stephen Nicholls, MD

SAHMRI Deputy Director and Heart Foundation Heart Health Theme Leader Professor of Cardiology University of Adelaide Consultant Cardiologist Royal Adelaide Hospital Adelaide, Australia